Fortive (FTV) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Fortive

NYSE•Technology•Scientific & Technical Instruments

$66.81-0.03(<0.01%)After hours

Market Cap

$20.07B

P/E

30.8x

P/S

5.9x

P/B

3.4x

Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

How this company scores

GoodMetricSide Score: 61/100

Strongest: Profitability (23/25); weakest: Growth (9/25).

Profitability23/25

Growth9/25

Balance Sheet & Red Flags11/25

Cash & Earnings Quality18/25

Strengths

Strong marginsCash-backed earningsConsistent free cash flowProfit converts from growth

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 30.8x5y range 22.0x – 35.7x

Currently above its 20-quarter median.

P/S · 5.9x5y range 2.7x – 5.9x

Currently above its 20-quarter median.

P/B · 3.4x5y range 1.6x – 3.4x

Currently above its 20-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Leverage Risk

Watch

Debt-to-equity has risen 81.5% recently — increasing financial risk even if the current ratio is manageable.

Revenue Decline

Red Flag

TTM revenue has contracted 39.4% — significant decline indicating deteriorating demand.

Price & Volume

Market Cap $20.07B

Metrics at a Glance

as of October 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $3.41B
Q. Revenue: $1.11B
TTM EBITDA: $1.19B
TTM Op. Income: $742.30M
Q. Op. Income: $235.90M
TTM Net Income: $651.90M
Q. Net Income: $172.50M
EPS: $0.57
Shares Out.: $300.40M

$3.41B in TTM revenue declined 39.5% YoY, reaching $1.11B last quarter. TTM EBITDA of $1.19B and TTM operating income of $742.30M show growth is flowing through to the bottom line. TTM net income of $651.90M means revenue is converting into profit. Over the past year, TTM revenue is down 39% — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 64.2%
EBITDA Margin: 31.4%
Op. Margin: 21.3%
Net Margin: 15.6%

Op. margin of 21.3% is up 5.8% YoY — cost efficiency is improving. Net margin at 15.6% and gross margin of 64.2% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 30.8x
P/S Ratio: 5.9x
P/B Ratio: 3.4x

At 30.8x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 5.9x and P/B of 3.4x provide additional context. P/E sits above typical market levels while revenue growth is below 5%. Over the past year, P/E is up 18% — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $11.50B
Cash: $377.30M
Long-Term Debt: $3.51B
Book Value: $5.95B
D/E Ratio: 0.6
Debt/EBITDA: 10.1

With $11.50B in assets and $3.51B in long-term debt, D/E is 0.6and book value is $5.95B — a conservative capital structure with a cushion to weather downturns. Across the last 8 quarters, debt/equity has risen for 5 consecutive quarters — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $313.20M
TTM Free Cash Flow: $1.09B
FCF Margin: 31.8%
FCF / Net Income: 1.7

TTM FCF of $1.09B on $313.20M in operating cash flow. The FCF / Net Income ratio of 1.7x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is down 2% — an improving trend.